FINancial Toxicity and CAncer REcovery in YOUNG Adults
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults. Basic parameters: 18 years — 50 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.
Primary outcome measures
- Financial toxicity [Time frame: From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.]
Eligibility criteria
Inclusion criteria
- Age 18 to 39 years at the time of initial cancer diagnosis
- Diagnosis of a malignant neoplasm
- Receipt of oncological treatment at the University Medical Center Göttingen
- Completion of primary cancer therapy at the time of study participation
- Initial diagnosis between 2014 and 2024
- Ability to provide informed consent
- Sufficient German language skills to participate in a telephone interview and complete questionnaires
Exclusion criteria
- Age below 18 years or above 39 years at the time of initial cancer diagnosis
- No history of malignant disease
- Ongoing primary cancer treatment at the time of study participation
- Severe cognitive impairment or psychiatric condition preventing reliable participation
- Insufficient German language proficiency to complete interviews or questionnaires
- Withdrawal of informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Germany · 1 center
- University Medicine Göttingen — Göttingen
Identifiers
NCT: NCT07314801 · 20/7/25